Literature DB >> 3145157

Use of transgenic animals to study human retroviruses.

S H Hinrichs1, J Vogel, M J Rhim, G Jay.   

Abstract

The purpose of transgenic technology is to introduce a gene into the germline of an animal in order to investigate its proper expression in the appropriate cell types and its effect on cellular functions. This technology has been used to explore a wide variety of genetic and biological issues including stage- and tissue-specific gene expression, development, immunology, oncology, and gene therapy. The intent of this article is to discuss the value of gene transfer technology for the study of mechanisms of viral pathogenesis. We will focus mainly on our experience with two experimental systems involving human T-lymphotropic virus Type 1 (HTLV-1) and human immunodeficiency virus Type 1 (HIV-1).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145157     DOI: 10.1007/bf00051372

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  51 in total

1.  Acquired immunodeficiency syndrome. Clinicopathologic study of 56 autopsies.

Authors:  G W Niedt; R A Schinella
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

2.  Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III.

Authors:  C A Rosen; J G Sodroski; W C Goh; A I Dayton; J Lippke; W A Haseltine
Journal:  Nature       Date:  1986 Feb 13-19       Impact factor: 49.962

3.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

4.  Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering.

Authors:  M Maruyama; H Shibuya; H Harada; M Hatakeyama; M Seiki; T Fujita; J Inoue; M Yoshida; T Taniguchi
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

5.  Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor.

Authors:  J Fujisawa; M Seiki; T Kiyokawa; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

6.  Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs.

Authors:  R L Brinster; H Y Chen; M E Trumbauer; M K Yagle; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

Authors:  B R Cullen
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

Review 8.  The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome.

Authors:  B Safai; K G Johnson; P L Myskowski; B Koziner; S Y Yang; S Cunningham-Rundles; J H Godbold; B Dupont
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

9.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

10.  Human T-cell leukemia virus type II transforms normal human lymphocytes.

Authors:  I S Chen; S G Quan; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

View more
  1 in total

Review 1.  Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesis.

Authors:  Shogo Ohkoshi; Haruka Hirono; Kazuhiko Watanabe; Katsuhiko Hasegawa; Masahiko Yano
Journal:  World J Hepatol       Date:  2015-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.